Continuous IV Infusion of 5-Flourouracil in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer

Clin Genitourin Cancer. 2022 Dec;20(6):586-590. doi: 10.1016/j.clgc.2022.06.014. Epub 2022 Jun 26.

¹ Tulane Cancer Center, Tulane University, New Orleans, LA.
² School of Medicine, Tulane University, New Orleans, LA.
³ Tulane Cancer Center, Tulane University, New Orleans, LA; School of Medicine, Tulane University, New Orleans, LA.
⁴ Tulane Cancer Center, Tulane University, New Orleans, LA; Deming Department of Medicine, Tulane University, New Orleans, LA.
⁵ Tulane Cancer Center, Tulane University, New Orleans, LA; School of Medicine, Tulane University, New Orleans, LA. Electronic address: [email protected].

No abstract available

Keywords: 5-fluorouracil; CRPC; Metastatic prostate cancer.

Publication types